StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
IRWD

Ironwood Pharmaceuticals, Inc.

IRWD Nasdaq Pharmaceutical Preparations EDGAR ↗
$4.42
+0.69 +18.50%

Key statistics

from XBRL data in SEC filings
Market cap
$728M
Revenue (TTM)
$362M
Net income (TTM)
$102M
EPS (TTM)
$0.60
P/E ratio
7.4
Dividend yield
Free cash flow
$127M
Cash
$220M
Total assets
$435M
Gross margin
52-week range
$0.72 – $5.78

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change; Shareholder vote results Jun 18, 2026 8-K Other events Jun 15, 2026 8-K/A Director or officer change May 21, 2026 8-K Director or officer change May 13, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Other events Mar 11, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 25, 2026 8-K Results of operations (earnings release) Jan 2, 2026 8-K Entered a material agreement; Other events Dec 23, 2025 8-K Other events Nov 26, 2025 8-K Results of operations (earnings release) Nov 10, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Director or officer change Oct 10, 2025 8-K Other events Sep 3, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Changed accountants Jul 10, 2025 8-K Shareholder vote results Jun 12, 2025 8-K Delisting notice or listing-rule failure Jun 3, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 7, 2025 8-K Results of operations (earnings release) Apr 25, 2025 8-K Other events Apr 14, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Delisting notice or listing-rule failure; Regulation FD disclosure Mar 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Exit or disposal costs; Director or officer change Jan 29, 2025 8-K Director or officer change Dec 5, 2024 8-K Director or officer change Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Other events Sep 30, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Shareholder vote results Jun 21, 2024 8-K Director or officer change; Other events Jun 20, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024